As of 2025-10-18, the Relative Valuation of Oric Pharmaceuticals Inc (ORIC) is (20.88) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.78 USD, the upside of Oric Pharmaceuticals Inc based on Relative Valuation is -263.3%.
The range of the Relative Valuation is (20.02) - (21.78) USD.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | 14.1x - 15.4x | 14.8x |
| Forward P/E multiples | 14.0x - 15.4x | 14.7x |
| Fair Price | (20.02) - (21.78) | (20.88) |
| Upside | -256.6% - -270.4% | -263.3% |
| Date | P/E |